Skip to content
AnalystLens

Idex Annual Report, Year Ended Dec 31, 2022

Filing Date
Filed February 23, 2023
Period End
December 31, 2022
Security
IEX
One revenue dollarkept$0.18
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · May ’22May ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 10-K filed February 23, 2023. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation's 2022 Form 10-K reports a record year in sales, driven by robust demand, with net sales of $3,181.9 milliona, up 15% from $2,764.8 million in 2021.

Organic sales rose 13%, and net income attributable to IDEX was $586.9 millionb, up 31%. Diluted EPS was $7.71, compared with $5.88 in 2021. Adjusted EBITDA reached $884.2 million, up 16%, with an Adjusted EBITDA margin of 27.9%.

Management attributes the results to price capture amid inflation, execution, and the acquisition of Nexsight, KZValve and Muon Group during 2022. Cash flow from operations was $557.4 millionc, down from $565.3 million, as higher earnings were more than offset by increased working capital investment. Free cash flow was $489.4 million, or 79.2% of adjusted net income attributable to IDEX.

Cash and cash equivalents fell to $430.2 million, and total borrowings rose to $1,477.8 milliond. The company repurchased 795,423 shares for $148.1 million and paid $177.4 million in dividends. Investing outflows of $917.2 million reflected acquisitions, including Muon Group for $713.0 million in cash.

The Company stated it expects to refinance or repay its $100.0 million 3.20% Senior Notes due June 2023 using Revolving Facility capacity, and it reports a net available revolver borrowing capacity of $714.4 million. For 2023, management's stated priorities are foundational execution, building global teams, and capital deployment, with $1.5 billion deployed over the last two years on growth opportunities and a stated expectation of a high-quality acquisition pipeline. Credit ratings are BBB (S&P), Baa2 (Moody's) and BBB+ (Fitch), and the company reports compliance with its financial covenants.

Key Highlights

  1. Net sales of $3,181.9 million, up 15%; organic sales up 13%, with a 5% increase from acquisitions net of divestitures and a 4% unfavorable foreign currency impact.
  2. Net income attributable to IDEX of $586.9 million, up 31%; diluted EPS of $7.71 versus $5.88; adjusted diluted EPS of $8.12, up 18%.
  3. Adjusted EBITDA of $884.2 million, up 16%, with a margin of 27.9%, up 20 basis points.
  4. Operating cash flow of $557.4 million and free cash flow of $489.4 million, which was 79.2% of adjusted net income attributable to IDEX.
  5. Acquisitions in 2022 included Nexsight, KZValve and Muon Group; the sale of Knight produced a pre-tax gain of $34.8 million.
  6. Shareholder returns included $148.1 million in share repurchases and $177.4 million in dividends paid; $563.8 million of repurchase authorization remained at year-end.
  7. Total borrowings of $1,477.8 million at December 31, 2022, with covenant compliance and credit ratings of BBB (S&P), Baa2 (Moody's) and BBB+ (Fitch).

Follow one dollar

Of each $1.00 of revenue in FY2022, Idex kept $0.18.

  1. Revenue$3.18B100.0%
  2. Cost of revenue−$1.75B55.2%
  3. Gross profit$1.43B44.8%
  4. Operating costs−$675.5M21.2%
  5. Operating income$751.4M23.6%
  6. Interest, other & tax−$164.7M5.2%
  7. Net income$586.7M18.4%
Computed from 10-KFY2022filed February 23, 2023Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2022 revenue went

$3.18B
  • Cost of revenue: $1.75B, 55% of revenue
  • SG&A: $652.7M, 21% of revenue
  • Net income: $586.7M, 18% of revenue
  • R&D: $61.4M, 1.9% of revenue
  • Interest, other & tax: $164.7M, 5.2% of revenue

Kept 18% as net income

Full revenue history →

Financial Statements

FY2022 against FY2021

Line itemFY2022FY2021Change
Revenue$3.18B$2.76B+15.1%
Cost of Revenue$1.75B$1.54B+13.9%
Gross Profit$1.43B$1.22B+16.5%
R&D Expenses$61.40M$50.10M+22.6%
SG&A Expenses$652.70M$578.20M+12.9%
Operating Income$751.40M$637.00M+18.0%
Interest Expense$40.70M$41.00M−0.7%
Net Income$586.70M$449.30M+30.6%
EPS (Basic)$7.74$5.91+31.0%
EPS (Diluted)$7.71$5.88+31.1%
Shares Outstanding (Basic)75.70M76.00M−0.4%
Shares Outstanding (Diluted)76.00M76.40M−0.5%

Frequently Asked Questions

  1. How did IDEX perform financially in 2022?

    Net sales rose 15% to $3,181.9 million, and net income attributable to IDEX rose 31% to $586.9 million. Diluted EPS was $7.71, compared with $5.88 in 2021. Operating income increased 18% to $751.4 million.

  2. Did cash generation keep pace with earnings growth?

    Not fully. Cash flows from operating activities decreased $7.9 million to $557.4 million because higher earnings were more than offset by an increased investment in working capital, including inventories, which rose $79.0 million. Free cash flow fell to $489.4 million from $492.6 million.

  3. How is IDEX deploying capital and funding acquisitions?

    In 2022 the company spent $945.6 million on acquisitions net of cash acquired, including Muon Group for $713.0 million, funded with cash on hand, Revolving Facility borrowings and Term Facility borrowings. It also repurchased $148.1 million of stock and paid $177.4 million in dividends. Management says it deployed $1.5 billion over the last two years and expects a high-quality acquisition pipeline in 2023.

  4. What debt obligations and liquidity does IDEX have?

    Total borrowings were $1,477.8 million at December 31, 2022. The company had $430.2 million of cash and cash equivalents and a net available Revolving Facility borrowing capacity of $714.4 million. It intends to refinance or repay its $100.0 million 3.20% Senior Notes due June 2023 using Revolving Facility capacity.

  5. What are the key priorities for IDEX in 2023?

    Management lists three priorities: foundational execution to drive efficiency, innovation and growth; building great global teams; and capital deployment into organic and inorganic opportunities. It anticipates 2023 organic investment will be in line with 2022 spending.